Kye Gilder

1.1k total citations
26 papers, 880 citations indexed

About

Kye Gilder is a scholar working on Surgery, Pharmacology and Molecular Biology. According to data from OpenAlex, Kye Gilder has authored 26 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Pharmacology and 5 papers in Molecular Biology. Recurrent topics in Kye Gilder's work include Pharmacology and Obesity Treatment (5 papers), Cervical and Thoracic Myelopathy (5 papers) and Diet and metabolism studies (4 papers). Kye Gilder is often cited by papers focused on Pharmacology and Obesity Treatment (5 papers), Cervical and Thoracic Myelopathy (5 papers) and Diet and metabolism studies (4 papers). Kye Gilder collaborates with scholars based in United States, Canada and Germany. Kye Gilder's co-authors include Paul C. McAfee, Fred H. Geisler, Kelli Howell, Christopher J. Reah, Frank M. Phillips, Ken Fujioka, Bryan W. Cunningham, John G. DeVine, Christopher D. Chaput and Brandon Walsh and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Kye Gilder

25 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kye Gilder United States	13	464	444	134	107	86	26	880
Akiro Higashikawa Japan	12	211 0.5×	181 0.4×	111 0.8×	219 2.0×	21 0.2×	45	599
Ely Ashkenazi Israel	17	452 1.0×	290 0.7×	96 0.7×	181 1.7×	26 0.3×	39	849
Severino Persechino Italy	12	122 0.3×	64 0.1×	13 0.1×	71 0.7×	44 0.5×	58	570
Lobke Gierman Norway	14	109 0.2×	44 0.1×	124 0.9×	149 1.4×	30 0.3×	29	655
Syed Hassan Ejaz Zaidi Canada	12	119 0.3×	38 0.1×	33 0.2×	132 1.2×	72 0.8×	27	570
Bengü Çobanoğlu Türkiye	12	84 0.2×	74 0.2×	19 0.1×	96 0.9×	100 1.2×	57	432
Alina Markova United States	14	69 0.1×	60 0.1×	57 0.4×	170 1.6×	120 1.4×	67	704
B.J. Pedersen Denmark	9	61 0.1×	107 0.2×	33 0.2×	204 1.9×	126 1.5×	9	729
Robert Daly United States	15	162 0.3×	42 0.1×	29 0.2×	362 3.4×	78 0.9×	22	866
RP Phipps United States	10	42 0.1×	55 0.1×	93 0.7×	108 1.0×	88 1.0×	14	585

Countries citing papers authored by Kye Gilder

Since Specialization

Citations

This map shows the geographic impact of Kye Gilder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kye Gilder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kye Gilder more than expected).

Fields of papers citing papers by Kye Gilder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kye Gilder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kye Gilder. The network helps show where Kye Gilder may publish in the future.

Co-authorship network of co-authors of Kye Gilder

This figure shows the co-authorship network connecting the top 25 collaborators of Kye Gilder. A scholar is included among the top collaborators of Kye Gilder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kye Gilder. Kye Gilder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

D’Haens, Geert, Stefan Schreiber, Vipul Jairath, et al.. (2025). Tamuzimod in patients with moderately-to-severely active ulcerative colitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 induction trial. The Lancet. Gastroenterology & hepatology. 10(3). 210–221. 4 indexed citations

Sands, Bruce E., Geert D’Haens, Stefan Schreiber, et al.. (2024). 987 EFFICACY AND SAFETY OF THE ORAL SELECTIVE SPHINGOSINE-1-PHOSPHATE-1 RECEPTOR MODULATOR VTX002 IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 TRIAL. Gastroenterology. 166(5). S–240.

Sands, B E, Remo Panaccione, Geert D’Haens, et al.. (2024). OP03 Efficacy and safety of the oral selective sphingosine-1-phosphate-1 receptor modulator VTX002 in moderately to severely active Ulcerative Colitis: results from a randomised, double-blind, placebo-controlled, phase 2 trial. Journal of Crohn s and Colitis. 18(Supplement_1). i4–i5. 5 indexed citations

Lee, Caroline A., Yong Tang, Ping Yi, et al.. (2023). Disposition and Mass Balance of Etrasimod in Healthy Subjects and In Vitro Determination of the Enzymes Responsible for Its Oxidative Metabolism. Clinical Pharmacology in Drug Development. 12(6). 553–571. 9 indexed citations

Chang, Lin, Brooks D. Cash, Anthony Lembo, et al.. (2023). Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo‐controlled trial (CAPTIVATE). Neurogastroenterology & Motility. 35(5). e14539–e14539. 23 indexed citations

Acevedo, Lisette M., Paramdeep Baweja, Kye Gilder, et al.. (2020). P396 Pharmacokinetics and circulating total lymphocyte count pharmacodynamic response from single and multiple oral doses of etrasimod in Japanese and Caucasian healthy male subjects. Journal of Crohn s and Colitis. 14(Supplement_1). S368–S368. 4 indexed citations

Yacyshyn, Bruce, Stephen B. Hanauer, Preston Klassen, et al.. (2020). Safety, Pharmacokinetics, and Efficacy of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, in a Phase 2a Study of Patients With Chronic Abdominal Pain Associated With Crohn’s Disease. Crohn s & Colitis 360. 3(1). otaa089–otaa089. 25 indexed citations

Yacyshyn, Bruce, Kye Gilder, Brandon Walsh, et al.. (2019). Su1930 – Safety and Efficacy of Olorinab, a Peripherally Restricted, Highly Selective, Cannabinoid Receptor 2 Agonist in a Phase 2A Study in Chronic Abdominal Pain Associated with Crohn’s Disease. Gastroenterology. 156(6). S–665. 15 indexed citations

Halseth, Amy E., et al.. (2018). Quality of life, binge eating and sexual function in participants treated for obesity with sustained release naltrexone/bupropion. Obesity Science & Practice. 4(2). 141–152. 22 indexed citations

10.

Halseth, Amy E., Kevin Shan, Kye Gilder, & John B. Buse. (2017). Effect on Body Weight of Naltrexone/Bupropion in Overweight and Obese Participants with Cardiovascular Risk Factors in a Large Randomized Double-Blind Study. 4(5). 1 indexed citations

11.

Fujioka, Ken, Raymond A Plodkowski, Patrick M. O’Neil, et al.. (2016). The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy. International Journal of Obesity. 40(9). 1369–1375. 57 indexed citations

12.

Halseth, Amy E., Kevin Shan, Brandon Walsh, Kye Gilder, & Ken Fujioka. (2016). Method‐of‐use study of naltrexone sustained release (SR)/bupropion SR on body weight in individuals with obesity. Obesity. 25(2). 338–345. 29 indexed citations

13.

Phillips, Frank M., Fred H. Geisler, Kye Gilder, et al.. (2015). Long-term Outcomes of the US FDA IDE Prospective, Randomized Controlled Clinical Trial Comparing PCM Cervical Disc Arthroplasty With Anterior Cervical Discectomy and Fusion. Spine. 40(10). 674–683. 175 indexed citations

14.

Kolotkin, Ronette L., et al.. (2015). Patient‐reported quality of life in a randomized placebo‐controlled trial of naltrexone/bupropion for obesity. Clinical Obesity. 5(5). 237–244. 15 indexed citations

15.

Phillips, Frank M., Fred H. Geisler, Andrew Cappuccino, et al.. (2013). A Prospective, Randomized, Controlled Clinical Investigation Comparing PCM Cervical Disc Arthroplasty With Anterior Cervical Discectomy and Fusion. Spine. 38(15). E907–E918. 162 indexed citations

16.

Greenwald, Maria, William Shergy, Jeffrey Kaine, et al.. (2011). Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: Results from a randomized controlled trial. Arthritis & Rheumatism. 63(3). 622–632. 73 indexed citations

17.

McAfee, Paul C., et al.. (2011). A Meta-Analysis of Comparative Outcomes Following Cervical Arthroplasty or Anterior Cervical Fusion. Spine. 37(11). 943–952. 82 indexed citations

18.

Bell‐McGuinn, Katherine M., Carolyn M. Matthews, Steffan N. Ho, et al.. (2011). A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer. Gynecologic Oncology. 121(2). 273–279. 144 indexed citations

19.

Howell, Kelli, Andrew Cappuccino, Fred H. Geisler, et al.. (2011). A Prospective, Randomized Clinical Investigation of the Porous Coated Motion (PCM) Artificial Cervical Disc: Two-Year Results from the US IDE Study. The Spine Journal. 11(10). S18–S18. 3 indexed citations

20.

Saville, M. Wayne, Nancy Valente, Kye Gilder, et al.. (2008). Evaluation of Humoral Immune Responses to Vaccination with Tetanus Toxoid and KLH in Rituximab-Treated Follicular Non-Hodgkin’s Lymphoma Patients Compared to Healthy Volunteers. Blood. 112(11). 3066–3066. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact